NL-OMON36546已完成不适用
The role of immunology in diabetes mellitus and pregnancy - Immunology in diabetes mellitus and pregnancy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Group 1: Pregnant women with DM1 >18 en <40 yrs
- •Group 2: Pregnant women with DM2 >18 en <40 yrs
- •Group 3: Healthy pregnant women >18 en <40 yrs
- •Group 4: Non-pregnant women with DM1 >18 and <40 yrs
- •Group 5: Non-pregnant women with DM2 >18 and <40 yrs
- •Group 6: Healthy non-pregnant women >18 en <40 yrs
排除标准
- •- HbA1c >7,5% after 30 weeks of gestation
- •- Renal failure (serum creatinine >120 µmol/L)
- •- Active treatment for auto-immune disease, except substitution therapy for primary hypothyroidism with TBII <1. ;Group 3:
- •- Gestational diabetes mellitus
- •- Intrauterine growth restriction (defined as foetal weight <10th percentile for gestational age).
- •- >2 times of miscarriage (defined as loss of pregnancy during the first 23 weeks of gestation)
- •- All other maternal and foetal complications
- •- Known active disease;Group 4, 5:
- •- HbA1c >7,5%
- •- Renal failure (serum creatinine >120 µmol/L)
- •- Active treatment for auto-immune disease, except substitution therapy for primary hypothyroidism with TBII <1. ;Group 6:
- •- Known active disease, except substitution therapy for primary hypothyroidism with TBII <1.
研究者
相似试验
尚未招募
不适用
Immunology in diabetic pregnancy.Immunological changes in diabetic pregnancy.NL-OMON23378niversity Medical Centre Groningen120
招募中
不适用
Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICINon Small Cell Lung Cancer MetastaticDiabetes MellitusNCT06100796Assiut University60
招募中
不适用
Immune Cells in Diabetic Chronic Foot UlcersImmune DefectDiabetic FootNCT06154915Karolinska Institutet40
尚未招募
1 期
The effect of inflammatory mechanism on diabetic limb arterial occlusion and the intervention of ruanjiantongmai granuleITMCTR2000003290Shanghai TCM-Integrated Hospita
尚未招募
不适用
Risk factors for diabetes induced by immune checkpoint inhibitorDiabetesJPRN-UMIN000028152Toranomon Hospital Department of Endocrinology and Metabolism.50